ClinicalTrials.gov
public full text
Public Domain
Phase 2 Study of Montelukast for the Treatment of Sickle Cell Anemia
In this feasibility trial, the investigators will compare participants treated with montelukast and hydroxyurea to those treated with placebo and hydroxyurea for a total of 8 weeks.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Effectiveness of Nontraditional Hydroxyurea Algorithms: Novel and Clinical Evaluations (ENHANCE)#1340392
- Research Study Investigating How Well NDec Works in People With Sickle Cell Disease#878507
- Long Term Effects of Hydroxyurea Therapy in Children With Sickle Cell Disease#1294250
- State Of The Art Functional Imaging In Sickle Cell Disease#878490
- Paediatric drug optimization for sickle cell disease: meeting report, 8-10 September 2025#429091
Record · ID 1444093
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive